L'Oreal S.A. Unsponsored ADR logo

L'Oreal S.A. Unsponsored ADR (LRLCY)

Market Closed
3 Jun, 20:00
OTC PINK OTC PINK
$
85. 68
-2.19
-2.4923%
$
238.82B Market Cap
39.08 P/E Ratio
1.42% Div Yield
18,421 Volume
0 Eps
$ 87.87
Previous Close
Add Transaction
Day Range
85.68 86.65
Year Range
78.82 95.48
Want to track LRLCY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
How Does Estée Lauder's Current Stock Performance Compare With That During The 2008 Market Crash?

How Does Estée Lauder's Current Stock Performance Compare With That During The 2008 Market Crash?

Estée Lauder stock (NYSE: EL) currently trades at $92 per share, around 75% below the level seen in December 2021. In comparison, L'Oréal (OTCMKTS: LRLCY) saw its stock decline 13% over the same period.

Forbes | 1 year ago
L'Oreal to acquire 10% stake in Swiss skin care company Galderma

L'Oreal to acquire 10% stake in Swiss skin care company Galderma

French cosmetics company L'Oreal is to acquire a 10% stake in Swiss skin care firm Galderma from a group of major shareholders, the two companies said on Monday.

Reuters | 1 year ago
L'Oreal acquires 105 stake in dermatology company Galderma

L'Oreal acquires 105 stake in dermatology company Galderma

L'Oreal has announced the acquisition of a 10% stake in dermatology solutions provider Galderma Group , the French cosmetics giant said in a statement on Monday.

Reuters | 1 year ago
L'Oréal S.A. (LRLCF) Q2 2024 Earnings Call Transcript

L'Oréal S.A. (LRLCF) Q2 2024 Earnings Call Transcript

L'Oréal S.A. (OTCPK:LRLCF) Q2 2024 Earnings Conference Call July 31, 2024 3:00 AM ET Company Participants Eva Quiroga - Head, IR Nicolas Hieronimus - CEO Christophe Babule - CFO Laurent Schmitt - Global Head, Corporate Finance and Financial Communications Conference Call Participants Iain Simpson - Barclays Celine Pannuti - JPMorgan Bruno Monteyne - Bernstein Guillaume Delmas - UBS Charles Scotti - Kepler Olivier Nicolai - Goldman Sachs Rogerio Fujimori - Stifel Tom Sykes - Deutsche Bank Ashley Wallace - Bank of America Operator Good morning, and welcome to the L'Oréal 2024 Half Year Results Conference Call.

Seekingalpha | 1 year ago
L'Oréal: Uncovering A Long-Term Growth Opportunity Amidst Market Challenges

L'Oréal: Uncovering A Long-Term Growth Opportunity Amidst Market Challenges

L'Oréal's stock price dropped due to the CEO's comments on the beauty industry and French election results. My valuation analysis shows L'Oréal is fairly valued with strong revenue growth, margins, and diversified portfolio. Despite short-term fluctuations, L'Oréal's stock is a good long-term investment due to its strong fundamentals and growth potential.

Seekingalpha | 1 year ago
Down 25% This Year Is Estée Lauder A Better Pick Over L'Oréal?

Down 25% This Year Is Estée Lauder A Better Pick Over L'Oréal?

Given its attractive valuation, we believe that Estée Lauder stock (NYSE: EL) is currently a better pick over its peer, L'Oréal stock (OTCMKTS: LRLCY). LRLCY stock trades at a higher valuation multiple of 5.7x revenues, versus 2.6x for EL stock.

Forbes | 1 year ago
L'Oreal: Great For The Long-Term Dividend Growth Investor, But Not At This Price

L'Oreal: Great For The Long-Term Dividend Growth Investor, But Not At This Price

L'Oréal is a high-quality company in the beauty industry with a track record of rapid earnings growth. The company is operating in an industry with a secular growth trend, has high margins, a solid balance sheet and a management team with significant skin in the game. Despite the relatively low dividend yield of 1.5%, the high, safe and constant dividend growth makes up for it.

Seekingalpha | 1 year ago
L'Oreal says it's working on a form of bioprinted skin that can actually ‘feel'

L'Oreal says it's working on a form of bioprinted skin that can actually ‘feel'

At the Viva Technology conference in Paris, L'Oreal showed off demonstrations of "bioprinting," technology that can 3D print humanlike skin, in action. The firm has been using this tech for several years to test new makeups on synthetic skin in its lab rather than animals.

Cnbc | 2 years ago